Paper455324
Adriamycin cardiotoxicity: a survey of 1273 patients.
Praga C and 23 others. Cancer Treat Rep, 1979. Cited by 281 papers, by iCite.
Cite this record
ConductScience Library. Adriamycin cardiotoxicity: a survey of 1273 patients. Papers, record 455324. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/455324
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomyopathies | Major topic |
| Doxorubicin | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Antineoplastic Agents | |
| Child | |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Electrocardiography | |
| Female | |
| Heart | |
| Humans | |
| Liver Function Tests | |
| Male | |
| Middle Aged | |
| Sex Factors |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41128656 | First-line Anlotinib plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft-Tissue Sarcoma: A Phase II Single-Arm Trial. | Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41128656 | PubMed |
| 40460832 | Visceral fat lipolysis by pancreatic lipases worsens heart failure. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40460832 | PubMed |
| 33889599 | Cardiac Energetics Before, During, and After Anthracycline-Based Chemotherapy in Breast Cancer Patients Using 31P Magnetic Resonance Spectroscopy: A Pilot Study. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/33889599 | PubMed |
| 33669040 | Consideration of Sex as a Biological Variable in the Development of Doxorubicin Myotoxicity and the Efficacy of Exercise as a Therapeutic Intervention. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33669040 | PubMed |
| 33530140 | Doxorubicin cardiotoxicity and target cells: a broader perspective. | Cardiooncology | 2016 | https://conductscience.org/library/papers/33530140 | PubMed |
| 33510932 | Methyl Gallate Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Suppressing Oxidative Stress. | Scientifica (Cairo) | 2021 | https://conductscience.org/library/papers/33510932 | PubMed |
| 32766291 | Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study. | Front Vet Sci | 2020 | https://conductscience.org/library/papers/32766291 | PubMed |
| 31918212 | Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model. | Transl Oncol | 2020 | https://conductscience.org/library/papers/31918212 | PubMed |
| 31187890 | Doxorubicin-Induced Cardiomyopathy in Children. | Compr Physiol | 2019 | https://conductscience.org/library/papers/31187890 | PubMed |
| 30634681 | Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells. | Biomolecules | 2019 | https://conductscience.org/library/papers/30634681 | PubMed |
| 30410442 | Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30410442 | PubMed |
| 30310418 | Chemotherapy-related Cardiomyopathy. | Eur Cardiol | 2015 | https://conductscience.org/library/papers/30310418 | PubMed |
| 29271920 | Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells. | Nanomaterials (Basel) | 2017 | https://conductscience.org/library/papers/29271920 | PubMed |
| 27342418 | Multiple impairments of cutaneous nociceptor function induced by cardiotoxic doses of Adriamycin in the rat. | Naunyn Schmiedebergs Arch Pharmacol | 2016 | https://conductscience.org/library/papers/27342418 | PubMed |
| 27142468 | Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes. | Sci Rep | 2016 | https://conductscience.org/library/papers/27142468 | PubMed |
| 25960114 | Management of Advanced Heart Failure due to Cancer Therapy: the Present Role of Mechanical Circulatory Support and Cardiac Transplantation. | Curr Treat Options Cardiovasc Med | 2015 | https://conductscience.org/library/papers/25960114 | PubMed |
| 25324877 | Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients. | J Clin Neurol | 2014 | https://conductscience.org/library/papers/25324877 | PubMed |
| 25226612 | Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin. | Oncotarget | 2015 | https://conductscience.org/library/papers/25226612 | PubMed |
| 25151211 | Cardiomyopathy associated with cancer therapy. | J Card Fail | 2014 | https://conductscience.org/library/papers/25151211 | PubMed |
| 25025013 | Abbreviated chemotherapy for limited-stage diffuse large B-cell lymphoma after complete resection. | Blood Res | 2014 | https://conductscience.org/library/papers/25025013 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/455324
GET https://conductscience.org/api/papers/v1/455324/authors?page=2